A case of keratin-positive acute myeloid leukemia: A possible role for cytokeratin 19 as a specific epithelial marker

Pathology

Volumn 32, Issue 2, 2000, Pages 98-101

  Turner, Jennifer J ^a   Milliken, Sam ^a  

^a ST VINCENT S HOSPITAL   (Australia)

Author keywords

Acute myeloid leukemia; AML; Cytokeratin 19; Immunochemistry keratin

Indexed keywords

BIOCHEMICAL MARKER; CHROMOGRANIN; CYTOKERATIN 19;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE MARKER; EPITHELIUM; FEMALE; HUMAN; IMMUNOCHEMISTRY; MERKEL CELL TUMOR; PROTEIN EXPRESSION; RELAPSE; SKIN CARCINOMA; SKIN INFILTRATE;

EID: 0034017679     PISSN: 00313025     EISSN: None     Source Type: Journal    
DOI: 10.1080/003130200104312     Document Type: Article

References (26)

1. 1. Traweek ST, Liu J, Battifora H. Keratin gene expression in non-epithelial tissues. Detection with polymerase chain reaction. Am J Pathol 1993; 142: 1111-8.
2. 2. Miettinen M. Keratin immunohistochemistry: update of applications and pitfalls. Pathol Annu 1993; 28 Pt 2: 113-43.
3. 3. Franke WW, Moll R. Cytoskeletal components of lymphoid organs. I. Synthesis of cytokeratins 8 and 18 and desmin in subpopulations of extrafollicular reticulum cells of human lymph nodes, tonsils and spleen. Differentiation 1987; 36: 145-63.
4. 4. Doglioni C, Dell'Orto P, Zanetti G, et al. Cytokeratin-immunoreactive cells of human lymph nodes and spleen in normal and pathological conditions. An immunohistochemical study. Virchows Arch A 1990; 416: 479-90.
5. 5. Gould VE, Bloom KJ, Franke WW, et al. Increased numbers of cytokeratin-positive interstitial reticulum cells (CIRC) in reactive, inflammatory and neoplastic lymphadenopathies: hyperplasia or induced expression? Virchows Arch 1995; 425: 617-29.
6. 6. De Mascarel A, Merlio J-P, Coindre J-M, et al. Gastric large cell lymphoma expressing cytokeratin but no leucocyte common antigen. A diagnostic dilemma. Am J Clin Pathol 1989; 91: 478-81.
7. 7. Frierson HF Jr, Bellafiore FJ, Gaffey MJ, et al. Cytokeratin in anaplastic large cell lymphoma. Mod Pathol 1994; 7: 317-21.
8. 8. Miettinen M, Lasota J. Cutaneous lymphoma-simulating Merkel cell carcinoma: molecular genetic demonstration of a clonal disease with divergent immunophenotypes. Mod Pathol 1995; 8: 769-74.
9. 9. Lasota J, Hyjek E, Koo CH, et al. Cytokeratin-positive large-cell lymphomas of B-cell lineage. A study of five phenotypically unusual cases verified by polymerase chain reaction. Am J Surg Pathol 1996; 20: 346-54.
10. 10. Menestrina F, Lestani M, Scarpa A, et al. Common acute lymphoblastic leukaemia-lymphoma expressing cytokeratin: a case report. Virchows Arch 1994; 425: 83-7.
11. 11. Ozdemirli M, Fanburg-Smith JC, Hartmann D-P, et al. Precursor B-lymphoblastic lymphoma presenting as a solitary bone tumor and mimicking Ewing's sarcoma. A report of four cases and review of the literature. Am J Surg Pathol 1998; 22: 795-804.
12. 12. Gustmann C, Altmannsberger M, Osborn M, et al. Cytokeratin expression and vimentin content in large cell anaplastic lymphomas and other non-Hodgkin's lymphomas. Am J Pathol 1991; 138: 1413-22.
13. 13. McCluggage WG, El-Agnaff M, O'Hara MD. Cytokeratin positive T cell malignant lymphoma. J Clin Pathol 1998; 51: 404-6.
14. 14. Sewell HF, Thompson WD, King DJ. IgD myeloma/immunoblastic lymphoma cells expressing cytokeratin. Br J Cancer 1986; 53: 695-6.
15. 15. Wotherspoon AC, Norton AJ, Isaacson PG. Immunoreactive cytokeratins in plasmacytomas. Histopathology 1989; 14: 141-50.
16. 16. Petruch UR, Horny H-P, Kaiserling E. Frequent expression of haemopoietic and non-haemopoietic antigens by neoplastic plasma cells: an immunohistochemical study using formalin-fixed, paraffin-embedded tissue. Histopathology 1992; 20: 35-40.
17. 17. Ladanyi M, Samaniego F, Reuter VE, et al. Cytogenetic and immunohistochemical evidence for the germ cell origin of a subset of acute leukemias associated with mediastinal germ cell tumour. J Natl Cancer Inst 1990; 82: 221-7.
18. 18. Gown AM, Boyd HC, Chang Y, et al. Smooth muscle cells can express cytokeratins of "simple" epithelium. Immunocytochemical and biochemical studies in vitro and in vivo. Am J Pathol 1988; 132: 223-32.
19. 19. Kwaspen FHL, Smedts FMM, Broos A, et al. Reproducible and highly sensitive detection of the broad spectrum epithelial marker keratin 19 in routine cancer diagnosis. Histopathology 1997; 31: 503-16.
20. 20. Datta YH, Adams PT, Drobyski WR, et al. Sensitive detection of occult breast cancer by the reverse-transcriptase polymerase chain reaction. J Clin Oncol 1994; 12: 475-82.
21. 21. Moscinski LC, Trudeau WL, Fields KK, Elfenbein GJ. High-sensitivity detection of minimal residual breast carcinoma using the polymerase chain reaction and primers for cytokeratin 19. Diagn Mol Pathol 1996; 5: 173-80.
22. 22. Krismann M, Todt B, Schroder J, et al. Low specificity of cytokeratin 19 reverse transcriptase-polymerase chain reaction analyses for detection of hematogenous lung cancer dissemination. J Clin Oncol 1995; 13: 2769-75.
23. 23. Novaes M, Bendit I, Garicochea B, del Giglio A. Reverse transcriptase-polymerase chain reaction analysis of cytokeratin 19 expression in the peripheral blood mononuclear cells of normal female blood donors. J Clin Pathol: Mol Pathol 1997; 50: 209-11.
24. 24. Hsu SM, Raine L, Fanger H. The use of antiavidin antibody and avidin-biotin-peroxidase complex in immunoperoxidase techniques. Am J Clin Pathol 1981; 75: 816-21.
25. 25. Swanson PE, Strickler JG. Comment in: Am J Clin Pathol 1989; 92: 707-9.
26. 26. Battifora H. Comment in: Am J Clin Pathol 1989; 92: 707-9.